SEARCH

SEARCH BY CITATION

References

  • 1
    Zetterström O, Fagerberg E, Wide L. An investigation of pollen extracts from different deciduous trees in patients with springtime allergy in Sweden. Acta Allergol 1972;27: 1521.
  • 2
    Mygind N, Nielsen LP, Hoffman H-J, Shukla A, Blumberga G, Dahl R et al. Mode of action of intranasal corticosteroid. J Allergy Clin Immunol 2001;108: S1625.
  • 3
    Varney VA, Gaga M, Frew AJ, Aber VR, Kay AB, Durham SR. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by anti-allergic drugs. BMJ 1991;302: 265269.
  • 4
    Arvidsson MB, Löwhagen O, Rak S. Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy. J Allergy Clin Immunol 2002;109: 777783.
  • 5
    Durham SR, Kay AB, Hamid Q. Changes in allergic inflammation associated with successful immunotherapy. Int Arch Allergy Immunol 1995;107: 282284.
  • 6
    Rak S, Heinrich C, Jacobsen L, Scheynius A, Venge P. A double-blinded comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma. J Allergy Clin Immunol 2001;108: 921928.
  • 7
    Fokkens WJ, Vroom TM, Gerritsma V, Rijntjes E. A biopsy method to obtain high quality specimens of nasal mucosa. Rhinology 1988;26: 293295.
  • 8
    Riske F, Hakimi J, Mallamaci M, Griffin M, Pilson B, Tobkes N et al. High affinity human IgE receptor (FcɛRI). Analysis of functional domains of the α-subunit with monoclonal antibodies. J Biol Chem 1991;266: 245251.
  • 9
    Papatziamos G, Hemlin C, van der Ploeg I, Patwardhan A, Scheynius A. Increased occurrence of IgE+ and FcɛRI+ cells in adenoids from atopic children. Allergy 1999;54: 916925.
  • 10
    Denburg JA, Inman MD, Leber B, Sehmi R, O'Byrne PM. The role of the bone marrow in allergy and asthma. Allergy 1996;51: 141148.
  • 11
    Holm AF, Fokkens WJ, Godthelp T, Mulder PG, Vroom TM, Rijntjes E. Effect of 3 months’ nasal steroid therapy on nasal T cells and Langerhans cells in patients suffering from allergic rhinitis. Allergy 1995;50: 204209.
  • 12
    Rak S, Jacobson MR, Sudderick RM, Masuyama K, Kay AB, Hamid Q et al. Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge. Clin Exp Allergy 1994;24: 930939.
  • 13
    Gomez E, Clague JE, Gatland D, Davies RJ. Effect of topical corticosteroids on seasonally induced increases in nasal mast cells. BMJ 1988;296: 15721573.
  • 14
    Howarth PH. The cellular basis for allergic rhinitis. Allergy 1995;50(Suppl. 23):610.
  • 15
    Pipkorn U, Proud D, Lichtenstein LM, Kagey-Sobotka A, Norman PS, Naclerio RM. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. N Engl J Med 1987;316: 15061510.
  • 16
    Weido AJ, Reece LM, Alam R, Cook CK, Sim TC. Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis. Ann Allergy Asthma Immunol 1996;77: 407415.
  • 17
    Fokkens WJ, Vroom TM, Rijntjes E, Mulder PG. Fluctuation of the number of CD-1(T6)-positive dendritic cells, presumably Langerhans cells, in the nasal mucosa of patients with an isolated grass-pollen allergy before, during, and after the grass-pollen season. J Allergy Clin Immunol 1989;84: 3943.
  • 18
    Till SJ, Jacobson MR, O'Brien F, Durham SR, KleinJan A, Fokkens WJ et al. Recruitment of CD1a+ Langerhans cell to the nasal mucosa in seasonal allergic rhinitis and effects of topical corticosteroid therapy. Allergy 2001;56: 126131.
  • 19
    Bradding P, Feather IH, Wilson S, Holgate ST, Howarth PH. Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid. Am J Respir Crit Care Med 1995;151: 19001906.
  • 20
    Nouri-Aria KT, Masuyama K, Jacobson MR, Rak S, Löwhagen O, Schotman E et al. Granulocyte/macrophage-colony stimulating factor in allergen-induced rhinitis: cellular localization, relation to tissue eosinophilia and influence of topical corticosteroid. Int Arch Allergy Immunol 1998;117: 248254.
  • 21
    Rajakulasingham K, Hamid Q, O'Brien F, Shotman E, Jose PJ, Williams TJ et al. RANTES in human allergen induced rhinitis: cellular source and relation to tissue eosinophilia. Am J Respir Crit Care Med 1997;155: 696703.
  • 22
    Rajakulasingam K, Durham SR, O'Brien F, Humbert M, Barata LT, Reece L et al. Enhanced expression of high-affinity IgE receptor (FcɛRI) α chain in human allergen-induced rhinitis with co-localization to mast cells, macrophages, eosinophils, and dendritic cells. J Allergy Clin Immunol 1997;100: 7886.
  • 23
    Pullerits T, Praks L, Sjöstrand M, Rak S, Skoogh BE, Lötvall J. An intranasal glucocorticoid inhibits the increase of specific IgE initiated during birch pollen season. J Allergy Clin Immunol 1997;100: 601605.
  • 24
    Haas N, Hamann K, Grabbe J, Niehus J, Kunkel G, Kolde G et al. Demonstration of the high-affinity IgE receptor (FcɛRI) on Langerhans’ cells of diseased nasal mucosa. Allergy 1997;52: 436439.
  • 25
    Maurer D, Fiebiger E, Reininger B, Wolff-Winiski B, Jouvin MH, Kilgus O et al. Expression of functional high affinity immunoglobulin E receptors (FcɛRI) on monocytes of atopic individuals. J Exp Med 1994;179: 745750.
  • 26
    MacGlashan DW Jr, Bochner BS, Adelman DC, Jardieu PM, Togias A, McKenzie-White J et al. Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol 1997;158: 14381445.
  • 27
    Otsuka H, Mezawa A, Ohnishi M, Okubo K, Seki H, Okuda M. Changes in nasal methachromatic cells during allergen immunotherapy. Clin Exp Allergy 1991;21: 115119.
  • 28
    Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay IS et al. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-γ. J Allergy Clin Immunol 1996;97: 13561365.